Susan Heavey
Susan Heavey
Lecturer in Translational Medicine, UCL
Verified email at - Homepage
Cited by
Cited by
Targeting nuclear factor-kappa B to overcome resistance to chemotherapy
P Godwin, AM Baird, S Heavey, MP Barr, KJ O’Byrne, K Gately
Frontiers in oncology 3, 120, 2013
Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
S Heavey, KJ O’Byrne, K Gately
Cancer treatment reviews 40 (3), 445-456, 2014
PIM kinase inhibition: Co-targeted therapeutic approaches in prostate cancer
S Luszczak, C Kumar, VK Sathyadevan, BS Simpson, KA Gately, ...
Signal transduction and targeted therapy 5 (1), 7, 2020
VERDICT MRI for prostate cancer: intracellular volume fraction versus apparent diffusion coefficient
EW Johnston, E Bonet-Carne, U Ferizi, B Yvernault, H Pye, D Patel, ...
Radiology 291 (2), 391-397, 2019
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of …
E Johnston, H Pye, E Bonet-Carne, E Panagiotaki, D Patel, M Galazi, ...
BMC cancer 16 (1), 1-11, 2016
MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype
N Lynam-Lennon, S Heavey, G Sommerville, BAS Bibby, B Ffrench, ...
Oncotarget 8 (7), 11400, 2017
Apparatus for histological validation of in vivo and ex vivo magnetic resonance imaging of the human prostate
RM Bourne, C Bailey, EW Johnston, H Pye, S Heavey, H Whitaker, B Siow, ...
Frontiers in oncology, 47, 2017
Strategic targeting of the PI3K–NFκB axis in cisplatin-resistant NSCLC
S Heavey, P Godwin, AM Baird, MP Barr, K Umezawa, S Cuffe, SP Finn, ...
Cancer biology & therapy 15 (10), 1367-1377, 2014
The oncogene metadherin interacts with the known splicing proteins YTHDC1, Sam68 and T-STAR and plays a novel role in alternative mRNA splicing
HJ Luxton, BS Simpson, IG Mills, NR Brindle, Z Ahmed, V Stavrinides, ...
Cancers 11 (9), 1233, 2019
In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC
S Heavey, S Cuffe, S Finn, V Young, R Ryan, S Nicholson, N Leonard, ...
Oncotarget 7 (48), 79526, 2016
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC
SL Ryan, S Beard, MP Barr, K Umezawa, S Heavey, P Godwin, SG Gray, ...
Lung Cancer 135, 217-227, 2019
An optimised saliva collection method to produce high-yield, high-quality RNA for translational research
R Sullivan, S Heavey, DG Graham, R Wellman, S Khan, S Thrumurthy, ...
PLoS One 15 (3), e0229791, 2020
Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer
T Malone, L Schäfer, N Simon, S Heavey, S Cuffe, S Finn, G Moore, ...
Pharmacology & Therapeutics 207, 107454, 2020
VERDICT MRI validation in fresh and fixed prostate specimens using patient‐specific moulds for histological and MR alignment
C Bailey, RM Bourne, B Siow, EW Johnston, M Brizmohun Appayya, ...
NMR in Biomedicine 32 (5), e4073, 2019
Cellular senescence as a possible link between prostate diseases of the ageing male
G Fiard, V Stavrinides, ES Chambers, S Heavey, A Freeman, R Ball, ...
Nature Reviews Urology 18 (10), 597-610, 2021
Evaluation of PSA and PSA density in a multiparametric magnetic resonance Imaging-Directed diagnostic pathway for suspected prostate cancer: the INNOVATE trial
H Pye, S Singh, JM Norris, LM Carmona Echeverria, V Stavrinides, A Grey, ...
Cancers 13 (8), 1985, 2021
Development and characterisation of a panel of phosphatidylinositide 3-kinase–mammalian target of rapamycin inhibitor resistant lung cancer cell lines
S Heavey, P Dowling, G Moore, MP Barr, N Kelly, SG Maher, S Cuffe, ...
Scientific Reports 8 (1), 1652, 2018
Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer
L Li, L Hobson, L Perry, B Clark, S Heavey, A Haider, A Sridhar, G Shaw, ...
British journal of cancer 123 (6), 1024-1032, 2020
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer
S Luszczak, BS Simpson, U Stopka-Farooqui, VK Sathyadevan, ...
Scientific reports 10 (1), 14380, 2020
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI‐characterized prostates
J Olivier, V Stavrinides, J Kay, A Freeman, H Pye, Z Ahmed, ...
The Prostate 78 (16), 1229-1237, 2018
The system can't perform the operation now. Try again later.
Articles 1–20